Cargando…

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression

BACKGROUND AND OBJECTIVES: Chronic active lesions contribute to multiple sclerosis (MS) severity, but their association with long-term disease progression has not been evaluated yet. White matter (WM) lesions showing linear expansion over time on serial T(1)- and T(2)-weighted scans (i.e., slowly ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Preziosa, Paolo, Pagani, Elisabetta, Meani, Alessandro, Moiola, Lucia, Rodegher, Mariaemma, Filippi, Massimo, Rocca, Maria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808355/ https://www.ncbi.nlm.nih.gov/pubmed/35105685 http://dx.doi.org/10.1212/NXI.0000000000001139

Ejemplares similares

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015)

Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study
por: Zanetta, Chiara, et al.
Publicado: (2023)

Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study
por: Zanetta, Chiara, et al.
Publicado: (2023)

Network Damage Predicts Clinical Worsening in Multiple Sclerosis: A 6.4-Year Study
por: Rocca, Maria A., et al.
Publicado: (2021)

Slowly expanding lesions are a marker of progressive MS – No
por: Arnold, Douglas L, et al.
Publicado: (2021)

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis
por: Calvi, Alberto, et al.
Publicado: (2022)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis
por: Elliott, Colm, et al.
Publicado: (2023)

Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015)

The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis
por: Albergoni, Matteo, et al.
Publicado: (2022)

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
por: Elliott, Colm, et al.
Publicado: (2018)

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?
por: Orrico, Mario, et al.
Publicado: (2021)

Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis
por: Calvi, Alberto, et al.
Publicado: (2022)

Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients
por: Santoro, Silvia, et al.
Publicado: (2022)

COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?
por: Gelibter, Stefano, et al.
Publicado: (2021)

Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction
por: Esposito, Federica, et al.
Publicado: (2015)

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
por: Filippi, Massimo, et al.
Publicado: (2019)

Slowly, slowly in the wind /
por: Highsmith, Patricia, 1921-1995
Publicado: (1981)

Mapping brain structure and function in professional fencers: A model to study training effects on central nervous system plasticity
por: Cordani, Claudio, et al.
Publicado: (2022)

Prognostic factors related to the risk of COVID-19 infection in MS patients
por: Montini, Federico, et al.
Publicado: (2021)

Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis
por: Sorosina, Melissa, et al.
Publicado: (2023)

Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective
por: Filippi, Massimo, et al.
Publicado: (2022)

The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis
por: Rocca, Maria A., et al.
Publicado: (2017)

Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study
por: Montini, Federico, et al.
Publicado: (2023)

A Patient with Slowly Progressive Proptosis
por: Dekeyzer, Sven
Publicado: (2017)

Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study
por: Kiljan, Svenja, et al.
Publicado: (2020)

Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report
por: Lazzarin, Serena Marita, et al.
Publicado: (2020)

Slowly progressive chest rash in an elderly woman
por: Tom, Lisa M., et al.
Publicado: (2018)

Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis
por: Rossi, Chiara, et al.
Publicado: (2018)

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Dysregulation of MS risk genes and pathways at distinct stages of disease
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

Eat Slowly
Publicado: (1895)

Hastening Slowly
Publicado: (1890)

Eat Slowly
Publicado: (1871)

Slowly progressing acute lymphoblastic leukemia with prolonged leukopenia
por: Sugisaki, Manato, et al.
Publicado: (2023)

Slow and Steady: A Slowly Progressing Neuroendocrine Tumor
por: Zheng, Christie, et al.
Publicado: (2023)

Editorial: “Inside-Out” vs “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
por: Luchicchi, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vve9crann5bcv5la50s9tu405m